HHealth Read More Rewiring Immune System Offers New Path to Better Ovarian Cancer TreatmentMarch 6, 2026 Newswise — Researchers at the University of California San Diego and collaborators have discovered a new way to…
TTechnology Read More What Full Body MRIs and Cancer Blood Tests Really OfferMarch 3, 2026 Mhttps://guardanthealth.com/pro…Y BROTHER’S EYESIGHT started to fail in February 2024. The problem came on suddenly: Text messages were blurry,…
NNutrition Read More SuppCo launches certification to verify actives in dietary supplementsMarch 3, 2026 The new program complements SuppCo’s TrustScore supplement quality rating system and builds on earlier testing initiatives, which revealed…
NNutrition Read More Why clinical trials on nutritional supplements are hard to designFebruary 27, 2026 Walk into any drugstore, natural market, or Costco and you’ll find a dazzling array of supplements promising everything…
HHealthcare Read More Klothea initiates longevity-focused human trial of klotho therapyFebruary 25, 2026 Recruitment for Phase 1 trial of mRNA therapy begins in ‘special economic zone’ on the Caribbean island of…
MMedication Read More Novartis remibrutinib first therapy to achieve Phase III primary endpoint in chronic inducible urticaria (CIndU)February 21, 2026 Statistically significant and clinically meaningful results seen in RemIND trial with complete responses achieved in 3 CIndU types1Remibrutinib,…
MMedication Read More Fact Check Team: GLP-1 users getting rare pirate diseaseFebruary 21, 2026 WASHINGTON (TNND) — Popular GLP-1 weight-loss medications have helped millions of people shed pounds, but new research from…
MMedication Read More Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPPFebruary 14, 2026 Disc Medicine Inc FDA acknowledged that AURORA and BEACON provided sufficient evidence that bitopertin significantly lowers PPIX and…
HHealth Read More Spanish scientist finds cure for pancreatic cancer in major medical breakthrough |January 29, 2026 A Spanish research team says it has developed a treatment that completely eliminated the most aggressive form of…
HHealthcare Read More FDA clears first human trial of epigenetic reprogramming therapyJanuary 28, 2026 A milestone moment for longevity as Life Biosciences gets green light to progress cellular rejuvenation trial in eye…
HHealth Read More Rheumatoid arthritis has no cure – but researchers are homing in on preventing itJanuary 24, 2026 But multiple studies have now confirmed that rheumatoid arthritis has a preclinical stage of development. This is a time about three…
HHealthcare Read More Juvena lands $33.5m to advance more regenerative biologics to the clinicJanuary 15, 2026 Co-founder Hanadie Yousef to step down as CEO as company gears up for more clinical trials of drugs…